Encephalitis, Tick-Borne: Clinical Trials

51 trials for Encephalitis, Tick-Borne, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 completed, 6 recruiting, 6 unknown, 2 not yet recruiting. 16 Phase 4, 10 Phase 2, 10 Phase 3, 3 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 416Completed 14, Unknown 2
Phase 210Completed 8, Terminated 1, Unknown 1
Phase 310Completed 9, Recruiting 1
Not applicable3Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 12Completed 1, Not yet recruiting 1

Follow Encephalitis, Tick-Borne: new trials by email Literature Review of Encephalitis, Tick-Borne trials Research Report on Encephalitis, Tick-Borne

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Human monoclonal antibody TBE025, intravenous infusion - The Tick-borne Encephalitis Virus (TBEV)
Phase 1Not yet recruitingGiuseppe Pantaleo182026-01-012026-01-29
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland
Tick Borne Encephalitis (TBE), Lyme Borreliosis
RecruitingTurku University Hospital8502025-04-232026-10-27
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
Dexamethasone in Tick-borne Encephalitis
Dexametasone, Saline (0.9% NaCl) - Tick-Borne Encephalitis
Phase 3RecruitingUniversity Medical Centre Ljubljana2002024-05-032026-05-13
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
Tick-borne Encephalitis, France
RecruitingUniversity Hospital, Strasbourg, France1002024-02-162025-09-24
Primary TBE Vaccination for the Elderly
FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine
Phase 4UnknownRegion Örebro County902024-01-012023-11-18
Tick-borne Encephalitis Virus Research in Limousin
anti-TBEV serology - Tick-borne Encephalitis
CompletedUniversity Hospital, Limoges8782023-07-172026-04-08
Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic
No intervention - Tick Borne Encephalitis (TBE)
RecruitingCharles University, Czech Republic2092023-04-012025-12-10
Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases
Tick-borne Encephalitis
CompletedUniversity Hospital, Strasbourg, France5002022-10-242026-10-23
Management of Tick-borne Encephalitis
No Intervention: Observational Cohort - Infectious Encephalitis
CompletedUniversity Medical Centre Ljubljana3182022-09-302024-12-13
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
TBE vaccine 0.5 mL, TBE vaccine 0.25 mL - Tick-Borne Encephalitis
Phase 3CompletedPfizer1652021-01-182023-11-22
The NOrwegian Tick-borne Encephalitis Study
No intervention - Tick-Borne Encephalitis, European
Active not recruitingSykehuset Telemark1532020-10-012024-09-25
Fever After Tick Bite Study
The proposed study is not interventional. - Tick-Bite; Fever, Tick Fever
WithdrawnGöteborg University2019-05-152025-04-09
Application of a TBE-Vaccine in Obese Persons
FSME-IMMUN Vaccine - Tick Borne Encephalitis
Phase 4UnknownMedical University of Vienna732015-04-152019-09-10
New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
FSME-immune - Tick-borne Encephalitis
Phase 2 / Phase 3CompletedSormland County Council, Sweden2502015-01-012021-02-10
Tick-borne Encephalitis and Borrelial Antibodies in Serum
Doxycycline, Symptomatic therapy, Questionnaire - Tick Borne Encephalitis
Not applicableRecruitingUniversity Medical Centre Ljubljana802014-09-012025-03-25
Tick-borne Encephalitis and Positive Borrelial Antibodies
Doxycycline, Symptomatic therapy, Questionnaire - Tick-borne Encephalitis
Not applicableUnknownUniversity Medical Centre Ljubljana1002014-09-012018-10-16
Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
TBE virus vaccine - Tick Borne Encephalitis
Phase 2CompletedMedical University of Vienna342014-07-012022-02-03
Aseptic Meningoencephalitis in Slovenia
symptomatic therapy, Ceftriaxone or Doxycycline, questionnaire - Aseptic Meningitis
UnknownUniversity Medical Centre Ljubljana8002014-06-012018-05-04

Showing 20 of 51. Sign in to see all of them.

Narrower conditions

Lyme Disease (3)  ·  Tick-Borne Diseases (3)  ·  Anaplasmosis (2)  ·  Brucellosis (2)  ·  Chikungunya Fever (2)  ·  Encephalitis (2)  ·  Hepatitis E (2)  ·  Leishmaniasis (2)  ·  Leptospirosis (2)  ·  Q Fever (2)  ·  Rickettsia Infections (2)  ·  Tick Bites (2)  ·  Zika Virus Infection (2)  ·  Adenoviridae Infections (1)

Broader conditions

Arbovirus Infections (51)  ·  Brain Diseases (51)  ·  Central Nervous System Diseases (51)  ·  Central Nervous System Infections (51)  ·  Central Nervous System Viral Diseases (51)  ·  Encephalitis, Arbovirus (51)  ·  Encephalitis, Viral (51)  ·  Flaviviridae Infections (51)  ·  Flavivirus Infections (51)  ·  Infections (51)  ·  Nervous System Diseases (51)  ·  Neuroinflammatory Diseases (51)  ·  RNA Virus Infections (51)  ·  Infectious Encephalitis (50)  ·  Vector Borne Diseases (50)

Interventions

Vaccines (9)  ·  Doxycycline (3)  ·  FSME-IMMUN vaccine (3)  ·  Surveys and Questionnaires (3)  ·  Blood Specimen Collection (2)  ·  Acyclovir (1)  ·  Ceftriaxone (1)  ·  Influenza Vaccines (1)  ·  Infusions, Intravenous (1)  ·  Sodium Chloride (1)

Sponsors

Pfizer (19)  ·  University Medical Centre Ljubljana (7)  ·  Medical University of Vienna (3)  ·  Novartis (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Sormland County Council, Sweden (2)  ·  University Hospital, Strasbourg, France (2)  ·  Charles University, Czech Republic (1)  ·  Elisabethinen Hospital (1)  ·  Giuseppe Pantaleo (1)  ·  GlaxoSmithKline (1)  ·  Göteborg University (1)  ·  Institut Pasteur du Cambodge (1)  ·  Novartis Vaccines (1)  ·  Region Örebro County (1)

Countries

Austria (12)  ·  Germany (11)  ·  Poland (9)  ·  Slovenia (7)  ·  Czechia (4)  ·  France (4)  ·  Sweden (4)  ·  Finland (3)  ·  Belgium (2)  ·  United States (2)  ·  Cambodia (1)  ·  Japan (1)  ·  Norway (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Ryszard Konior, MD (3)  ·  Jerzy Brzostek, MD (2)  ·  Jerzy Dziduch, MD (2)  ·  Jerzy Romaszko, MD (2)  ·  Krzysztof Sladek, MD (2)  ·  Marian Patrzalek, MD (2)  ·  Ulrich Behre, MD (2)  ·  Ursula Wiedermann-Schmidt, MD, PhD (2)  ·  Anna Durbin, MD (1)

Results publications

PMID 21592984, PMID 28545923, PMID 25728316, PMID 30928173, PMID 32528467, PMID 32728481, PMID 34452033, PMID 35101266, PMID 38614954, PMID 41610944

NIH funding

2008 (1), 2009 (1)